We are live on ! Find out more
Cambridge Investment Research Advisors

Cambridge Investment Research Advisors Portfolio holdings

AUM $44.6B
1-Year Est. Return 28.94%
This Fund
S&P 500
This Quarter Est. Return
-0.75%
1 Year Est. Return
+28.94%
3 Year Est. Return
+82.62%
5 Year Est. Return
+90.41%
10 Year Est. Return
+293.66%
AUM
$20.3B
AUM Growth
-$658M
Cap. Flow
-$389M
Cap. Flow %
-1.92%
Top 10 Hldgs %
19.94%
Holding
3,276
New
193
Increased
1,504
Reduced
1,271
Closed
193

Sector Composition

Rank Sector Weight
1 Technology 9.58%
2 Consumer Discretionary 4.97%
3 Financials 4.87%
4 Healthcare 3.87%
5 Communication Services 3.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DXYN
3001
DELISTED
Dixie Group Inc
DXYN
$66K ﹤0.01%
13,550
+1,240
+10% +$4.84K
EPZM
3002
DELISTED
Epizyme, Inc
EPZM
$64K ﹤0.01%
12,500
VMD icon
3003
Viemed Healthcare
VMD
$353M
$63K ﹤0.01%
11,340
DMK
3004
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
$63K ﹤0.01%
926
ADNWW
3005
DELISTED
Advent Technologies Holdings Warrant
ADNWW
$62K ﹤0.01%
39,000
-1,000
-3% -$1.23K
SID icon
3006
Companhia Siderúrgica Nacional
SID
$1.15B
$62K ﹤0.01%
+11,755
New +$88.3K
KPTI icon
3007
Karyopharm Therapeutics
KPTI
$46M
$61K ﹤0.01%
695
ENDP
3008
DELISTED
Endo International plc
ENDP
$60K ﹤0.01%
+18,405
New +$65K
GSAT icon
3009
Globalstar
GSAT
$10.8B
$59K ﹤0.01%
2,347
+659
+39% +$16.2K
CENN icon
3010
Cenntro
CENN
$8.53M
$57K ﹤0.01%
9
+2
+29% +$10.7K
NRO
3011
Neuberger Real Estate Securities Income Fund Inc
NRO
$188M
$56K ﹤0.01%
12,201
-1,177
-9% -$5.72K
SLVO icon
3012
Credit Suisse X-Links Silver Shares Covered Call ETNs due April 21 2033
SLVO
$12.5M
$56K ﹤0.01%
555
-195
-26% -$21.7K
REFR icon
3013
Research Frontiers
REFR
$16.8M
$55K ﹤0.01%
21,466
CHS
3014
DELISTED
Chicos FAS, Inc.
CHS
$54K ﹤0.01%
+11,973
New +$68.4K
SENS icon
3015
Senseonics Holdings Inc
SENS
$419M
$52K ﹤0.01%
769
+48
+7% +$3.26K
VANI icon
3016
Vivani Medical
VANI
$118M
$52K ﹤0.01%
5,383
LOTZ
3017
DELISTED
CarLotz, Inc. Class A Common Stock
LOTZ
$52K ﹤0.01%
13,601
-500
-4% -$2.16K
VHC icon
3018
VirnetX Holding Corp
VHC
$65.8M
$49K ﹤0.01%
629
-10
-2% -$818
VVOS icon
3019
Vivos Therapeutics
VVOS
$3.97M
$48K ﹤0.01%
480
-1,022
-68% -$107K
DHF
3020
BNY Mellon High Yield Strategies Fund
DHF
$175M
$47K ﹤0.01%
14,585
+274
+2% +$927
PHX
3021
DELISTED
PHX Minerals
PHX
$47K ﹤0.01%
15,467
+2,470
+19% +$7.26K
OGI
3022
Organigram Holdings
OGI
$182M
$46K ﹤0.01%
4,944
+995
+25% +$10.2K
CFMS
3023
DELISTED
Conformis, Inc. Common Stock
CFMS
$46K ﹤0.01%
1,381
+160
+13% +$5.64K
IPOD.WS
3024
DELISTED
Social Capital Hedosophia Holdings Corp. IV Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
IPOD.WS
$46K ﹤0.01%
26,000
+6,000
+30% +$11.3K
SUPV
3025
Grupo Supervielle
SUPV
$725M
$45K ﹤0.01%
20,002
+2
+0% +$4

Similar funds

Cambridge Investment Research Advisors's Q3 2021 Portfolio in Review

As of Q3 2021, Cambridge Investment Research Advisors held 3,276 positions worth $20.3B, down 3.1% from $20.9B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Cambridge Investment Research Advisors's Q3 2021 filing shows 193 new, 1,504 increased, 1,271 reduced and 193 closed positions. Its largest new stake was Dimensional World ex US Core Equity 2 ETF: 269,623 shares worth $6.98M. The largest sale was iShares S&P 500 Growth ETF, an estimated $90.8M.

By sector, the portfolio is most concentrated in Technology at 9.6% of assets, up from 9.3% a quarter earlier, followed by Consumer Discretionary and Financials.

  • Cambridge Investment Research Advisors's largest Q3 2021 buy was Dimensional World ex US Core Equity 2 ETF: 269,623 shares worth $6.98M.
  • Cambridge Investment Research Advisors added most to iShares Core S&P US Growth ETF in Q3 2021, an estimated $42.5M increase.
  • Cambridge Investment Research Advisors's biggest Q3 2021 reduction was iShares S&P 500 Growth ETF, cutting an estimated $90.8M.
  • Cambridge Investment Research Advisors fully exited VanEck Steel ETF in Q3 2021, selling an estimated $6.22M.
  • Cambridge Investment Research Advisors's ten largest holdings make up 20% of its $20.3B portfolio in Q3 2021.
  • Cambridge Investment Research Advisors opened 193 new positions and closed 193 in Q3 2021.
  • Cambridge Investment Research Advisors's portfolio value fell 3.1% quarter-over-quarter to $20.3B.

Based on Cambridge Investment Research Advisors's 13F filing for Q3 2021, filed 2 Nov 2021.